These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3376183)

  • 1. Pharmacokinetics of diazepam during multiple dosing of a 6-mg controlled-release capsule once daily.
    Silvestri TM; Wills RJ
    Ther Drug Monit; 1988; 10(1):64-8. PubMed ID: 3376183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of diazepam following once-daily administration of a controlled-release capsule.
    Wills RJ; Colburn WA
    Ther Drug Monit; 1983; 5(4):423-6. PubMed ID: 6419420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-dose pharmacokinetics of naproxen from a controlled-release tablet in healthy volunteers.
    Palazzini E; Galli G; Babbini M
    Int J Clin Pharmacol Res; 1990; 10(5):277-84. PubMed ID: 2079385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation.
    Hing JP; Piotrovsky V; Kimko H; Brashear HR; Zhao Q
    Curr Med Res Opin; 2005 Apr; 21(4):483-8. PubMed ID: 15899095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK; Sathyan G
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
    Widerlöv E; Franzén G; Jansson P; Movin G
    Int Clin Psychopharmacol; 1990 Apr; 5(2):125-34. PubMed ID: 1974271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of diazepam from a controlled release capsule in healthy elderly volunteers.
    Wills RJ
    Biopharm Drug Dispos; 1984; 5(3):241-9. PubMed ID: 6487752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study for diazepam commercial tablets in psychiatric patients.
    Domínguez A; Cortés A; Cárdenas H; Galindo MC; Helgi JC
    Arch Med Res; 1994; 25(1):23-7. PubMed ID: 8019110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state pharmacokinetics of phentermine extended-release capsules.
    Groenewoud G; Schall R; Hundt HK; Müller FO; van Dyk M
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):368-72. PubMed ID: 8225680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.